Caffeine Withdrawal: A Parametric Analysis of Caffeine Dosing Conditions
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Although caffeine is the most widely used behaviorally active drug in the world, caffeine physical dependence has been only moderately well characterized in humans. Four double-blind experiments were conducted in independent groups of healthy participants to assess the conditions under which withdrawal symptoms occur upon cessation of low to moderate doses of caffeine. In experiment 1, there was no evidence that the range or magnitude of caffeine withdrawal symptoms differed when 300 mg of caffeine was consumed as a single dose in the morning versus 100 mg at three time points across the day. In experiment 2, both the range and severity of withdrawal increased as a function of caffeine maintenance dose (100, 300, and 600 mg/day), with even the lowest dose (100 mg) producing significant caffeine withdrawal. Experiment 3 showed that when individuals were maintained on 300 mg caffeine/day and tested with a range of lower doses (200, 100, 50, 25, and 0 mg/day), a substantial reduction in caffeine consumption (</=100 mg/day) was necessary for the manifestation of caffeine withdrawal. Experiment 4 manipulated duration of exposure to caffeine (1, 3, 7, or 14 days of 300 mg/day) and showed that caffeine withdrawal occurred after as little as 3 days of caffeine exposure, with a somewhat increased severity of withdrawal observed after 7 or 14 days of exposure. As a whole, this set of experiments provides the most complete parametric characterization of caffeine withdrawal to date and suggests that caffeine physical dependence can occur under more modest conditions (i.e., fewer doses per day, lower daily dose, shorter duration of exposure) than previously recognized.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“levels below 1 μg/ml have previously been reported for overnight caffeine abstinence (Evans and Griffiths 1999)”
From A Double-Blind, Placebo-Controlled Study Evaluating the Effects of Caffeine and L-Theanine Both Alone and in Combination on Cerebral Blood Flow, Cognition and Mood (2015) · cites this paper as Evans and Griffiths 1999
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McNair, D. M. (1992) · Medical Entomology and Zoology · Cited by 2,692
Psychopharmacology: The Fourth Generation of Progress
Green, A. I. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.312 · Cited by 1,145
Barone, J. J., & Roberts, H. R. (1996) · Food and Chemical Toxicology · doi:10.1016/0278-6915(95)00093-3 · Cited by 705
Jacob, P., Wilson, M., & Benowitz, N. L. (1981) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)81033-6 · Cited by 448
Withdrawal Syndrome after the Double-Blind Cessation of Caffeine Consumption
Silverman, K., Evans, S. M., Strain, E. C., & Griffiths, R. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210153271601 · Cited by 380 · cited 4×
“, 1971) and has been shown previously to be sensitive to the effects of caffeine and caffeine withdrawal (Griffiths et al., 1990a,b; Evans and Griffiths, 1992; Silverman et al., 1992).”
InfluentialSelf-citationCaffeine physical dependence: a review of human and laboratory animal studies
Griffiths, R. R., & Woodson, P. P. (1988) · Psychopharmacology · doi:10.1007/bf00212836 · Cited by 276
Self-citationGoldstein, A., Kaizer, S., & Whitby, O. (1969) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1969104489 · Cited by 199
Caffeine dependence syndrome. Evidence from case histories and experimental evaluations
Strain, E. C. (1994) · JAMA · doi:10.1001/jama.272.13.1043 · Cited by 199
Anxiety and depression associated with caffeinism among psychiatric inpatients
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.8.963 · Cited by 189
Research works printed but not linked: 2
- Dreisbach, 1943, Caffeine-withdrawal headache., J Lab Clin Med, 28, 1212
- Hughes, 1992, Caffeine self-administration and withdrawal in soda drinkers., J Addict Dis, 4, 178
Cited by
DSM-5 criteria for substance use disorders: recommendations and rationale
Hasin, D. S., O’Brien, C. P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W. M., Crowley, T., Ling, W., Petry, N. M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060782 · Cited by 1,622
Caffeine and Exercise: Metabolism, Endurance and Performance
Graham, T. E. (2001) · Sports Medicine · doi:10.2165/00007256-200131110-00002 · Cited by 819
Juliano, L. M., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2000-x · Cited by 581
Self-citationCaffeine as a psychomotor stimulant: mechanism of action
Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3269-3 · Cited by 538
Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications
Carrillo, J. A., & Benitez, J. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039020-00004 · Cited by 364
Metadata
- Authors
- Evans, S. M., & Griffiths, R. R.
- Affiliations
- Johns Hopkins University (US)
- ORCID
- Evans, Suzette M.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1999-04
- Volume
- 289
- Issue
- 1
- Pages
- 285-294
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2098001354
- Cited by
- 145
- References
- 40
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 6 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 1 · 2013: 5 · 2012: 9
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institute on Drug Abuse (R01 DA03890, R01DA003890)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- caffeine, caffeine withdrawal, physical dependence, caffeine dose, withdrawal symptoms, parametric study
- MeSH terms
- Adult, Central Nervous System Stimulants, Caffeine, Diet, Double-Blind Method, Female, Humans, Male, Surveys and Questionnaires, Saliva, Substance Withdrawal Syndrome, Cluster Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Caffeine Withdrawal: A Parametric Analysis of Caffeine Dosing Conditions. https://app.cochat.ai/papers/10.1016/s0022-3565(24)38135-2
- The paper
- Evans, S. M., & Griffiths, R. R. (1999). Caffeine Withdrawal: A Parametric Analysis of Caffeine Dosing Conditions. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(24)38135-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.